期刊文献+

小剂量肝素对脓毒症大鼠的早期干预作用 被引量:1

Effects of low-dose heparin on sepsis rats in early stage
暂未订购
导出
摘要 目的观察小剂量肝素对脓毒症大鼠的早期干预作用。方法雌性Wistar大鼠96只,随机分为假手术组(8只)、脓毒症组(44只)、肝素干预组(44只),以盲肠结扎穿孔法复制大鼠脓毒症模型。于不同时间点观察各组大鼠凝血酶原时间、活化部分凝血酶时间(APTT)及血小板(PLT)、巨噬细胞移动抑制因子(MIF)水平变化;光镜下观察大鼠肺脏组织病理学的改变,计算大鼠48 h病死率。结果肝素干预组MIF水平较脓毒症组降低(P<0.01),肺组织损伤减轻,APTT升高及PLT降低的程度较脓毒症组减轻(P均<0.05)。结论早期应用小剂量肝素可改善脓毒症凝血功能紊乱,明显降低血清MIF水平,减轻肺脏组织损伤程度。 Objective To observe the effects of low-dose heparin on sepsis rats in early stage. Methods A total of 96 female Wistar rats was randomly divided into sham operation group( n = 8 ), sepsis group( n = 44) and heparin interfere group (n =44). Sepsis rats models were prepared by cecal ligation and puncture (CLP). PT, APTr in plasma and PLT in blood were observed at different times, MIF level was detected by ELISA. The pathological changes in lung tissues were observed with microscope after HE staining, the mortality for 48 hours after CLP was evaluated. Results In heparin interfere group, the MIF level was markedly decreased, and lung injury was lessened( P 〈 0.01 ) , the changes of APTT and PLT levels were attenuate( all P 〈 0.05). Conclusion Low-dose heparin used early could ameliorate the disorder of blood coagulation, and markedly decrease the plasmic MIF level as well as lung injury.
出处 《山东医药》 CAS 北大核心 2010年第13期19-21,共3页 Shandong Medical Journal
基金 山东省自然科学基金资助项目(Z2007C10)
关键词 脓毒症 巨噬细胞移动抑制因子 肝素 sepsis macrophage migration inhlbitozy factor beparin
  • 相关文献

参考文献3

二级参考文献45

  • 1刘辉,姚咏明,董月青,于燕,盛志勇.高迁移率族蛋白B1诱导巨噬细胞Janus激酶/信号转导及转录激活子通路活化的研究[J].中国危重病急救医学,2004,16(10):592-595. 被引量:10
  • 2李海燕,梁欢,卢中秋,胡国新,王明山,邱俏檬,李景荣.抗菌药物对创伤弧菌脓毒症大鼠血清抗炎/促炎细胞因子的影响[J].中国危重病急救医学,2007,19(1):53-54. 被引量:11
  • 3Cornet AD, Smit EG, Beishuizen A,et al. The role of heparin and allied compounds in the treatment of sepsis [ J ]. Thromb Haemost, 2007,98 ( 3 ) :579-86.
  • 4American College of Chest Physicians-Society of Critical Care Medicine Consensus Conference. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis [ J ]. Crit Care Med, 1992,20 (6) : 864-874.
  • 5Clemens F, Christian JW. Effects of anti-coagulant strategies on acti- vation of inflammation and coagulation [ J ], Expert Opin Biol Ther, 2007,7 (6) : 855-870.
  • 6Gando S, Saitoh D, Ogura H,et al. Natural history of disseminated intravascular coagulation diagnosed based on the newly established diagnostic criteria for critically ill patients : Results of a muhicenter, prospective survey[ J ]. Crit Care Med ,2008,36 : 145-150.
  • 7Lothar Thamas,主编,朱汉民等译.临床实验诊断学:实验结果的应用和评估[M].上海:上海科学技术出版社,2004:525-601.
  • 8Bernard GR,Vincent JL, Laterre PF,et al. Efficacy and safety of recombinant human activated protein C for severe sepsis [ J ]. N Engl J Med ,2001,344:699-709.
  • 9Robertson MS. Heparin: the cheap alternative for immunomodulation in sepsis [ J ] ? Crit Care Resusc ,2006,8 (3) :235-238.
  • 10Wiedermann CJ. Molecular mechanisms underlying the role of antithrombin in sepsis [ J ]. Critical Care,2006,10:209.

共引文献14

同被引文献10

  • 1Chaudry I H, Wichterman K A, Baue A E. Effect of sepsis on tissue adenine nucleotide levels [J]. Surgery, 1979,85 (2): 205-211.
  • 2Marcel S, Willem J W, Marcel L, et al. Inflammation, endothelium, and coagulation in sepsis [J]. J Leukoc Biol, 2008, 83 (3) : 536-545.
  • 3Cinel I, Opal S M. Molecular biology of inflammation and sepsis: A primer [J]. Crit Care Med, 2009,37(1): 291-304.
  • 4Tohyamal S, Onoderal S, Tohyamal H, vaccine-targeting macrophage migration et al. A novel DNA inhibitory factor improves the survival of mice with sepsis [J]. Gene Therapy 2008,15(23) : 1513-1522.
  • 5Zhang Y, Zeng X G, Chen S, identification and mechanisms et al. Characterization, epitope of the anti-septic capacity of monoclonal antibodies against macrophage migration inhibitory factor [J]. Int Immunopharmacol, 2011,11 (9) : 1333-1340.
  • 6Calandra T, Echtenacher B, Roy D L, et al. Protection from septic shock by neutralization of macrophage migration inhibitory factor [J]. Nat Med, 2000,6(2) : 164-170.
  • 7Hochart H, Jenkins P V, Smith O P, et al. Low-molecular weight andunfractionated heparin sinduce a downregulation of inflammation:decreased levels of proinflammatory cytokines and nuclear factor-κB in LPS-stimulated human monocytes [J]. Br J Haematol, 2006,133( 1 ) :62-67.
  • 8彭娜,向定成,苏磊,张亚松.脓毒症大鼠心肌内皮素-1、肿瘤坏死因子-α表达与心肌损伤的关系[J].实用医学杂志,2010,26(6):944-946. 被引量:25
  • 9高原,吕长俊,王晓芝,张晓荣,韩兆东,逯峰.小剂量肝素对脓毒症大鼠早期的干预作用[J].滨州医学院学报,2010,33(2):95-98. 被引量:2
  • 10蔡爱东,刘勇,肖岳,缪红军,杨军,王晓榕,喻文亮,江涛,李军.脓毒症患儿凝血功能紊乱的临床研究[J].实用医学杂志,2010,26(10):1766-1767. 被引量:13

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部